RUBY
Rubius Therapeutics Inc

2,064
Mkt Cap
$5.15M
Volume
755,858.00
52W High
$0.3763
52W Low
$0.0032
PE Ratio
-0.03
RUBY Fundamentals
Price
$0.057
Prev Close
$0.0555
Open
$0.0555
50D MA
$0.0217
Beta
1.65
Avg. Volume
45,333.00
P/B
0.34
Loading...
Loading...
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Rubius Therapeutics Inc?
What is the 52-week high for Rubius Therapeutics Inc?
What is the 52-week low for Rubius Therapeutics Inc?
What is Rubius Therapeutics Inc stock price today?
What was Rubius Therapeutics Inc stock price yesterday?
What is the PE ratio of Rubius Therapeutics Inc?
What is the Price-to-Book ratio of Rubius Therapeutics Inc?
What is the 50-day moving average of Rubius Therapeutics Inc?

Latest RUBY News

View
No RUBY news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.